ATE421693T1 - Proteine in der diabetes-proteomanalyse - Google Patents

Proteine in der diabetes-proteomanalyse

Info

Publication number
ATE421693T1
ATE421693T1 AT02742845T AT02742845T ATE421693T1 AT E421693 T1 ATE421693 T1 AT E421693T1 AT 02742845 T AT02742845 T AT 02742845T AT 02742845 T AT02742845 T AT 02742845T AT E421693 T1 ATE421693 T1 AT E421693T1
Authority
AT
Austria
Prior art keywords
diabetes
proteom
proteins
analysis
human
Prior art date
Application number
AT02742845T
Other languages
English (en)
Inventor
Peter Larsen
Stephen Fey
Joern Nerup
Allan Karlsen
Karin Nielsen
Original Assignee
Pride Proteomics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pride Proteomics As filed Critical Pride Proteomics As
Application granted granted Critical
Publication of ATE421693T1 publication Critical patent/ATE421693T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02742845T 2001-05-29 2002-05-29 Proteine in der diabetes-proteomanalyse ATE421693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100852 2001-05-29

Publications (1)

Publication Number Publication Date
ATE421693T1 true ATE421693T1 (de) 2009-02-15

Family

ID=8160539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02742845T ATE421693T1 (de) 2001-05-29 2002-05-29 Proteine in der diabetes-proteomanalyse

Country Status (4)

Country Link
EP (2) EP2161578A1 (de)
AT (1) ATE421693T1 (de)
DE (1) DE60230988D1 (de)
WO (1) WO2002097434A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521193B2 (en) * 2002-03-20 2009-04-21 Pride Proteomics A/S Human diabetes-mediating proteins
JP2006528361A (ja) * 2004-07-06 2006-12-14 クンイル ファーマシューティカル カンパニー リミテッド アルドラーゼを含む網膜血管疾患診断用組成物およびその診断方法
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
JP5386350B2 (ja) 2006-05-31 2014-01-15 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020124A2 (en) * 1996-10-25 1998-05-14 Peter Mose Larsen Diabetes-mediating proteins and therapeutic uses thereof
US6753314B1 (en) * 1999-04-01 2004-06-22 Curagen Corporation Protein-protein complexes and methods of using same
MXPA01009962A (es) * 1999-04-02 2002-08-20 Corixa Corp Compuestos y metodos para terapia y diagnostico de cancer de pulmon.
JP2003503676A (ja) * 1999-06-01 2003-01-28 プロティオーム・サイエンシィズ・ピーエルシー インスリン抵抗性疾患に関する方法及び組成物
GB9914890D0 (en) * 1999-06-25 1999-08-25 Univ Buckingham Methods and compositions relating to pancreatic islet and -cell dysfunction

Also Published As

Publication number Publication date
EP1402257A1 (de) 2004-03-31
WO2002097434A1 (en) 2002-12-05
EP2161578A1 (de) 2010-03-10
DE60230988D1 (de) 2009-03-12
EP1402257B1 (de) 2009-01-21

Similar Documents

Publication Publication Date Title
DE60041839D1 (de) Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
ATE283485T1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
DK221090A (da) Fremgangsmaade og apparat til diagnostisk analyse ved stroemmaaling
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
ATE520026T1 (de) Sequenzielle analyse biologischer proben
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
ATE496294T1 (de) Analyseset mit stechhilfe und messgerät
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
SE8802944L (sv) Material foer lapptestning
NO953770L (no) Analysemetode
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
DE59911255D1 (de) ELISPOT-Verfahren zur Quantifizierung der Aktivität von menschlichen und tierischen Zellen, zur insbesondere Blutzellen
EP1560025A3 (de) Marker spezifisch für Diabetes
EP2071338A3 (de) Menschliche Diabetes-vermittelnde Proteine
WO2005119209A3 (en) System and method for analyzing microbial growth
WO2003099107A3 (en) Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
AU6366798A (en) Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers
DE59710505D1 (de) Verwendung von tiefgefrorenem Blut für biologische Untersuchungsverfahren
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DK1393078T3 (da) Fremgangsmåder til diagnosticering in vitro eller til overvågning af en sygdom involverende en inflammatorisk reaktion
BR0317224A (pt) Processo de detecção de prp (proteìna priÈnio nativa) com uso de um antibiótico dos aminoglicosìdeos
ATE278965T1 (de) Knorpelresorptionsassays
DE60018063D1 (de) Platform für chemische und biologische analyse mit mikrowaage, analysegerät und verfahren zur verwendung derselben
ATE447045T1 (de) Assoziation von proteinpolymorphismen mit koronarer herzkrankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties